Enochian BioSciences Inc logo

Enochian BioSciences Inc

$ 1.76 +0.02 (+1.15%) 10:08 PM EST
P/E:
At Loss
P/B:
0.58
Market Cap:
$ 93.19M
Enterprise V:
$ 89.36M
Volume:
7.56K
Avg Vol (2M):
41.19K
Also Trade In:
Volume:
7.56K
Market Cap $:
93.19M
PE Ratio:
At Loss
Avg Vol (2-Month):
41.19K
Enterprise Value $:
89.36M
PB Ratio:
0.58
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Enochian BioSciences Inc is a biopharmaceutical company. It is engaged in identifying, developing, manufacturing, and commercializing gene therapies. The company develops cures and providing prevention for infectious diseases and cancer. It is also engaged in developing HIV preventative vaccines and cures and Cellular immune-oncology products.
Name Current Vs Industry Vs History
Cash-To-Debt 1.52
Equity-to-Asset 0.9
Debt-to-Equity 0.05
Debt-to-EBITDA -0.18
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Beneish M-Score -0.88
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 48.71
9-Day RSI 45.62
14-Day RSI 45.53
6-1 Month Momentum % -46.22
12-1 Month Momentum % -81.88

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.56
Quick Ratio 1.56
Cash Ratio 1.48

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -13

Profitability Rank

Name Current Vs Industry Vs History
ROE % -24.41
ROA % -22.27
ROIC % -18.72
ROC (Joel Greenblatt) % -1956.76
ROCE % -22.51

GF Value Rank

Name Current Vs Industry Vs History
PB Ratio 0.58
EV-to-EBIT -2.22
EV-to-EBITDA -2.25
EV-to-FCF -3.47
Price-to-Projected-FCF 2.38
Earnings Yield (Greenblatt) % -45.05

Financials (Next Earnings Date:2022-11-30 Est.)

ENOB's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ENOB

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.82
Beta 1.5
Volatility % 119.03
14-Day RSI 45.53
14-Day ATR ($) 0.170797
20-Day SMA ($) 1.8435
12-1 Month Momentum % -81.88
52-Week Range ($) 1.42 - 13.7799
Shares Outstanding (Mil) 52.95

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Enochian BioSciences Inc Filings

Document Form Filing Date
No Filing Data

Enochian BioSciences Inc Analysis

Share your research

Headlines

See More
No news.